Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NIPRO JMI Pharma is a leading pharmaceutical company in Bangladesh, established as a joint venture between the Japanese multinational Nipro Corporation and the local JMI Group. The company specializes in the manufacturing and marketing of a diverse range of high-quality generic medicines across various therapeutic categories, including cardiovascular, gastrointestinal, and respiratory health. With a state-of-the-art manufacturing facility that adheres to international standards like WHO-GMP, NIPRO JMI Pharma serves both the domestic Bangladeshi market and international export markets. The company leverages Japanese technology and quality control standards to provide affordable healthcare solutions. It is recognized as the first joint venture pharmaceutical company in Bangladesh involving a Japanese partner.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NIPRO JMI Pharma.